Vinehealth, a London-based AI platform that aims to improve the quality of life and survival of cancer patients, has secured a £1 million Biomedical Catalyst grant. The funding will be used to improve cancer patient self-management and data collection across the UK healthcare system.

Highly personalised patient support

Founded by Georgina Kirby, and Rayna Patel, Vine Health provides intelligent digital technology to support people going through cancer treatment to manage their care, using a combination of behavioural science and AI.

Further, patients can regularly enter outcome data to support clinical decision-making, inform service delivery and drive clinical research.

Highest-rated cancer app

Notably, Vinehealth has been announced as the highest-rated cancer app in the world by leading organisation ORCHA, where Vinehealth scored 93%, over 10% higher than any other cancer tool. 

Vinehealth works with the UK’s leading charities, such as CRUK, Macmillan, and Bowel Cancer UK, whose invaluable supportive content features in the app. 

Vinehealth’s CEO, Rayna Patel says that “Providing remote patient support and enabling clinicians to understand how their patients are doing remotely is crucial in a post-pandemic world. Vinehealth is at the forefront of this shift, and we are delighted to be recognised in the way by Innovate UK”. Innovate the UK received 373 submitted applications, approximately triple the usual number, and was able to fund 18 projects. The lowest score of the funded project was 60%, with Vinehealth scoring a phenomenal 86.8%” – a fantastic achievement for the Vinehealth team. 

In 2020, Vinehealth was a winner of the NHSx Techforce19 grant, partnering with The Royal Marsden, a world-leading cancer centre to fulfil the scope of supporting the mental health and well-being of cancer patients during the COVID-19 pandemic.